Name: ANAVEX LIFE SCIENCES CORP (AVXL) Stock
Brand: ANAVEX LIFE SCIENCES CORP
Rating: 4 (3 reviews)

AVXL Latest News, Press Relases and Analysis

All

Press Releases

21 days ago - By: Chartmill

Anavex Life Sciences Corp (NASDAQ:AVXL) Surges on Better-Than-Expected Q4 2025 Earnings

3 days ago - By: Stocktwits - Mentions: IWMW EAOR ORCL

Anavex Stock Slides After Hours On EMA Panel’s Negative Alzheimer’s Drug Opinion — Retail Traders Talk Buyout Potential

3 days ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease

5 days ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

6 days ago - By: Schall Law

AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm

12 days ago - By: The Schall Law Firm

AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm

14 days ago - By: Zacks Investment Research

Down 50.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Anavex Life Sciences (AVXL)

20 days ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

20 days ago - By: The Motley Fool

Anavex (AVXL) Q4 2025 Earnings Call Transcript

20 days ago - By: Stocktwits - Mentions: IWMW EAOR

AVXL Stock Jumps On Lower Q4 Loss, Anticipation For EMA Approval Of Alzheimer’s Drug

21 days ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update

a month ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

a month ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference

a month ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

a month ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025

a month ago - By: Stocktwits

Anavex Retail Traders See Silver Lining In EMA Committee Postpones Alzheimer’s Drug Verdict: Delay 'Actually A Positive Sign'

a month ago - By: Benzinga - Mentions: PTN ZYXI CDTX CMND ...

12 Health Care Stocks Moving In Friday's Intraday Session

a month ago - By: Benzinga - Mentions: VSTM TSSI SEI RCAT ...

Red Cat Posts Downbeat Q3 Results, Joins StubHub, WhiteFiber And Other Big Stocks Moving Lower In Friday's Pre-Market Session

a month ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease

a month ago - By: Stocktwits

AVXL Shares Slump Pre-market After EMA Committee Fails To Recommend Approval For Alzheimer’s Drug

a month ago - By: Stocktwits

Anavex Stock Just Logged Its Worst Selloff In 2 Years — What Does EMA’s Oral Explanation Week Mean For Its Alzheimer’s Drug?

a month ago - By: Stocktwits - Mentions: IWMW EAOR

AVXL Stock Draws Retail Attention Ahead Of Company’s Meeting With EMA Committee

2 months ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group

2 months ago - By: Stocktwits

Anavex Life Sciences Stock Sparks Retail Banter On Hopes Of EMA Conditional Nod For Alzheimer's Drug, Big Pharma Tie-Up

2 months ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’

2 months ago - By: Stocktwits - Mentions: EAOR ITOT

Anavex Life Sciences Stock Just Shot Up 7% Today – Here’s An Important Update

2 months ago - By: Anavex Life Sciences Corp.

Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program

2 months ago - By: Anavex Life Sciences Corp.

ANAVEX LIFE SCIENCES CORP (AVXL) Stock News

AVXL Latest News, Press Relases and Analysis

Anavex Life Sciences Corp (NASDAQ:AVXL) Surges on Better-Than-Expected Q4 2025 Earnings

Anavex Stock Slides After Hours On EMA Panel’s Negative Alzheimer’s Drug Opinion — Retail Traders Talk Buyout Potential

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm

AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm

Down 50.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Anavex Life Sciences (AVXL)

Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Anavex (AVXL) Q4 2025 Earnings Call Transcript

AVXL Stock Jumps On Lower Q4 Loss, Anticipation For EMA Approval Of Alzheimer’s Drug

Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025

Anavex Retail Traders See Silver Lining In EMA Committee Postpones Alzheimer’s Drug Verdict: Delay 'Actually A Positive Sign'

12 Health Care Stocks Moving In Friday's Intraday Session

Red Cat Posts Downbeat Q3 Results, Joins StubHub, WhiteFiber And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease

AVXL Shares Slump Pre-market After EMA Committee Fails To Recommend Approval For Alzheimer’s Drug

Anavex Stock Just Logged Its Worst Selloff In 2 Years — What Does EMA’s Oral Explanation Week Mean For Its Alzheimer’s Drug?

AVXL Stock Draws Retail Attention Ahead Of Company’s Meeting With EMA Committee

Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group

Anavex Life Sciences Stock Sparks Retail Banter On Hopes Of EMA Conditional Nod For Alzheimer's Drug, Big Pharma Tie-Up

Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’

Anavex Life Sciences Stock Just Shot Up 7% Today – Here’s An Important Update

Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program

Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia